Neil Herskowitz - Sep 23, 2024 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
Director
Signature
/s/ David Jin, Attorney-in-Fact
Stock symbol
ATXI
Transactions as of
Sep 23, 2024
Transactions value $
$0
Form type
4
Date filed
9/25/2024, 04:57 PM
Previous filing
Jul 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXI Employee stock option (right to buy) Award $0 +30K $0.00 30K Sep 23, 2024 Common Stock 30K $2.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027.